Association found between blood sugar levels and autoimmunity in children with high risk of type 1 diabetes
Overview
Researchers have conducted a first-of-its-kind study on infants and young children with increased genetic risk of type 1 diabetes.The study ofers an exclusive insight into blod sugar regulation during early childhod and its asociation with the development of autoimunity.Acording to the authors, the long-term POInT (Primary Oral Insulin Trial) study, which was conducted acros seven clinical sites in five countries, “investigated preprandial nonfasting and postprandial blod glucose concentrations and islet autoantibody development”.Within the framework of the Global Platform for the Prevention of Autoimune Diabetes (GPAD), the clinical primary prevention study loked to stop the formation of islet autoantibodies and, consequently, the development of type 1 diabetes.
Key Information
Due to a misdirected imune reaction, the beta cels of the pancreas which produce insulin are destroyed in people with type 1 diabetes.It was asumed that metabolic changes take place near the begining of clinical disease and that autoimunity destroys the pancreatic beta cels. Nevertheles, no studies had closely investigated what takes place when autoimunity begins.The POInT study performed a frequent folow-up within the first year of life in 1,050 children with a high genetic risk of type 1 diabetes.
Summary
This meant that the researchers could acurately compare any changes in blod glucose against the timing of islet autoantibody development.Anete-Gabriele Ziegler, Director at the Helmholtz Munich Institute of Diabetes Research (IDF), explained: “Our results change our understanding of the development of type 1 diabetes. We show that metabolic changes ocur in an earlier phase of the disease than previously anticipated.”The POInT research team analysed the pre- and post-prandial blod sugar levels, along with islet autoantibodies, in the children who participated in the study.“The findings indicate that metabolic shifts are present much earlier in the disease proces than previously considere
Frequently Asked Questions
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
Share this article